Instructions for Nobazit (Enisamium iodide) 20 pills 250 mg
English product name
nobazite
Release form
tab, film coating, 125 mg: 10 or 20 pcs
tab, film coating, 250 mg: 10 or 20 pcs
Description Nobazit:
Tablets covered with a film shell of yellow color, round, double-convex; Cross-section: light yellow to yellow or yellow with a greenish tint.
1 tab.
enisamia iodide (100% anhydrous) 125 mg
Auxiliary substances:
(core) lactose monohydrate (breast sugar) - 33.4 mg,
cellulose microcrystalline (vivapur 101) - 10 mg,
sucrose (refined sugar) - 9 mg,
povidone (polyvinylpyrrolidone low-molecular medical or plasdon K-17) - 3.6 mg,
copovidone (plasdon S-630) - 1.4 mg,
crospovidone (polyplasdon XL-10) - 3.8 mg,
talc - 1.9 mg,
calcium stearate - 1.9 mg.
Shell Composition:
Aquarius Prime BAN314047 Yellow - 6 mg (hypromellose - 3.96 mg,
titanium dioxide - 1.3437 mg,
capril/caprilate (caprile/caprine triglyceride) - 0.54 mg,
iron oxide yellow dye - 0.042 mg,
iron oxide red dye - 0.0003 mg,
quinoline yellow dye - 0.114 mg).
10 pcs - packages of contour compartments (1) - cardboard packs.
10 pcs - packages of contour compartments (2) - cardboard packages.
ATC codes
J05AX Other antiviral drugs
Clinical-pharmacological groups / Group affiliation
An antiviral and immunomodulating preparation. Interferon synthesis inductor
Active substance
enisamia iodide
Pharmacotherapy group Nobazit
Antiviral agent
Testimony Nobazit:
- Treatment of influenza and other ARVIs,
- including complex therapy.
Method of use, course and dosage Nobazit:
Inside. Individual dosing regime, depending on indications and clinical situation.
Use in renal dysfunction
It is not recommended for use in severe renal dysfunction.
Use in case of impaired liver function
It is not recommended for use in severe violations of liver function.
Use in elderly patients
There are no specific restriction guidelines for use.
Use in children
Contraindicated in children and adolescents under the age of 18 years.
- Nosology (ICD codes)
- J06.9
- Acute upper respiratory tract infection unspecified
- J10
- Influenza caused by an identified seasonal influenza virus
Pharmacological effect Nobazit:
An antiviral agent derived from isonicotinic acid. It effectively suppresses the action of influenza viruses and other causative agents of acute respiratory viral infections (SARS) due to direct (inhibiting) effect on the process of virus penetration through the cell membrane.